英文摘要 |
Particulate matter in large volume parenteral solutions (LVP) is a complex subject. It may be generated in sterile packaging operations at any point in the packaging process, from the packaging material to the final packaging operations. This article contains a general review of the progress made in assessing particles in injectables, a discussion of the nature and sources of particulate contamination including packaging material, manufacturing variables, formulation components, the sets and devices used in administration, the manipulation involving medical staff, and miscellaneous factors. The pathological hazards and clinical significance of such contamination is described. In addition, the current pharmacopoeia limit test for particulate contamination in LVP is presented. Finally, a variety of official instrumental methods for the determination of particulate matter in LVP, including microescopic, electrical zonesensing, light blockage techniques. Each of these particle counting methods is discussed. |